The antibody response of pregnant Cameroonian women to VAR2CSA ID1–ID2a, a small recombinant protein containing the CSA-binding site
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
In pregnant women, Plasmodium falciparum-infected erythrocytes expressing the VAR2CSA antigen bind to chondroitin sulfate A in the placenta causing placental malaria. The binding site of VAR2CSA is present in the ID1-ID2a region. This study sought to determine if pregnant Cameroonian women naturally acquire antibodies to ID1-ID2a and if antibodies to ID1-ID2a correlate with absence of placental malaria at delivery. Antibody levels to full-length VAR2CSA and ID1-ID2a were measured in plasma samples from 745 pregnant Cameroonian women, 144 Cameroonian men, and 66 US subjects. IgM levels and IgG avidity to ID1-ID2a were also determined. As expected, antibodies to ID1-ID2a were absent in US controls. Although pregnant Cameroonian women developed increasing levels of antibodies to full-length VAR2CSA during pregnancy, no increase in either IgM or IgG to ID1-ID2a was observed. Surprisingly, no differences in antibody levels to ID1-ID2a were detected between Cameroonian men and pregnant women. For example, in rural settings only 8-9% of males had antibodies to full-length VAR2CSA, but 90-96% had antibodies to ID1-ID2a. In addition, no significant difference in the avidity of IgG to ID1-ID2a was found between pregnant women and Cameroonian men, and no correlation between antibody levels at delivery and absence of placental malaria was found. Thus, the response to ID1-ID2a was not pregnancy specific, but predominantly against cross-reactivity epitopes, which may have been induced by other PfEMP1 antigens, malarial antigens, or microbes. Currently, ID1-ID2a is a leading vaccine candidate, since it binds to the CSA with the same affinity as the full-length molecule and elicits binding-inhibitory antibodies in animals. Further studies are needed to determine if the presence of naturally acquired cross-reactive antibodies in women living in malaria endemic countries will alter the response to ID1-ID2a following vaccination with ID1-ID2a.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Antibody levels to N-terminal fragments of VAR2CSA are similar between men, primigravid and multigravid women in Africa [40].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 32 · Cited by 26
Research works printed but not linked: 1
- L Manga, 1992, Le paludisme urbain a Yaoundé, Cameroon: l'etude entomologique dans deux quartiers centraux, Mem Soc R Belg Entomol, 35, 155
Metadata
- Authors
- Babakhanyan, A., Leke, R. G. F., Salanti, A., Bobbili, N., Gwanmesia, P., Leke, R. J. I., Quakyi, I. A., Chen, J. J., & Taylor, D. W.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Université de Yaoundé I (CM)
- University of Copenhagen (DK)
- University of Ghana (GH)
- Corresponding author
- Taylor, Diane Wallace
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-04
- Volume
- 9
- Issue
- 2
- Pages
- e88173
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3913775
- OpenAlex
- W2042169301
- Cited by
- 26
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2021: 2 · 2020: 5 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 1
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- University of Hawai'i (U54MD007584, G12MD007601)
- European Commission (200889)
- National Institutes of Health (FP7/2007-2013, G12-MD007601)
- National Institute of Allergy and Infectious Diseases (UO1AI43888, R01AI071160, RO1AI071160, U01AI043888)
- Fogarty International Center (R25TW009345)
- National Institute on Minority Health and Health Disparities (NIH G12MD007601, U54MD007584, G12MD007601, NIMHD U54MD007584)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- VAR2CSA, placental malaria, Plasmodium falciparum, chondroitin sulfate A, cross-reactive antibodies, PfEMP1, IgG avidity, IgM, vaccine candidate, placenta
- MeSH terms
- Adolescent, Adult, Antibodies, Protozoan, Antibody Formation, Epitopes, Antigens, Protozoan, Binding Sites, Cameroon, Cross Reactions, Erythrocytes, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Placenta, Plasmodium falciparum, Pregnancy, Recombinant Proteins, Pregnancy Complications, Parasitic, Malaria, Falciparum, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The antibody response of pregnant Cameroonian women to VAR2CSA ID1–ID2a, a small recombinant protein containing the CSA-binding site. https://app.cochat.ai/papers/10.1371/journal.pone.0088173
- The paper
- Babakhanyan, A., Leke, R. G. F., Salanti, A., Bobbili, N., Gwanmesia, P., Leke, R. J. I., Quakyi, I. A., Chen, J. J., & Taylor, D. W. (2014). The antibody response of pregnant Cameroonian women to VAR2CSA ID1–ID2a, a small recombinant protein containing the CSA-binding site. PLoS ONE. https://doi.org/10.1371/journal.pone.0088173
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.